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The regulation of mRNA translation is of fundamental
importance in biological mechanisms ranging from
embryonic axis specification to the formation of
long-term memory. POS-1 is one of several CCCH
zinc-finger RNA-binding proteins that regulate cell
fate specification during C. elegans embryogenesis.
Paradoxically, pos-1mutants exhibit striking defects
in endo-mesoderm development but have wild-type
distributions of SKN-1, a key determinant of endo-
mesoderm fates. RNAi screens forpos-1 suppressors
identified genes encoding the cytoplasmic poly(A)-
polymerasehomologGLD-2, theBicaudal-Chomolog
GLD-3, and the protein NEG-1. We show that NEG-1
localizes in anterior nuclei, where it negatively
regulates endo-mesoderm fates. In posterior cells,
POS-1 binds the neg-1 30 UTR to oppose GLD-2 and
GLD-3 activities that promote NEG-1 expression and
cytoplasmic lengthening of the neg-1 mRNA poly(A)
tail. Our findings uncover an intricate series of post-
transcriptional regulatory interactions that, together,
achieve precise spatial expression of endo-meso-
derm fates in C. elegans embryos.
INTRODUCTION
Eukaryotic cells exercise remarkable control over the post-tran-
scriptional expression of mRNA. This is most notable in special-
ized cells such as large polarized embryonic cells and neurons,
where a host of RNA-binding factors have been shown to regu-108 Developmental Cell 34, 108–118, July 6, 2015 ª2015 Elsevier Inclate the spatial and temporal expression of mRNAs by control-
ling mRNA translation, stability, and localization within the cell
(Darnell and Richter, 2012; Richter and Lasko, 2011). Translation
efficiency for mRNAs is often positively correlated with poly(A)
tail length, whereas tail shortening is frequently associated with
mRNA turnover (Eckmann et al., 2011; Mangus et al., 2003).
However, for somemRNAs, tail shortening does not lead to turn-
over but, instead, correlates with storage. Cytoplasmic poly(A)
tail lengthening can restore translation of these stored mRNAs
(Weill et al., 2012). The conserved cytoplasmic poly(A) polymer-
ase GLD-2 has been implicated in lengthening poly(A) tails and
activating the translation of mRNAs in the C. elegans germline
(Wang et al., 2002), mouse and frog oocytes (Barnard et al.,
2004; Kwak et al., 2004; Nakanishi et al., 2006), and Drosophila
embryos (Cui et al., 2008).
GLD-2 polyadenylation of its targets is thought to be regulated
through RNA-binding co-factors (D’Ambrogio et al., 2013). For
example, in C. elegans, GLD-2 binds to the conserved K homol-
ogy (KH) domain protein GLD-3, a homolog of Drosophila Bicau-
dal-C (Eckmann et al., 2004). GLD-3 stimulates GLD-2 activity
in vitro (Wang et al., 2002). In addition, GLD-2 polyadenylation
of gld-1 mRNA requires both GLD-3 and the RNA-binding
domain-containing protein RNP-8 (Kim et al., 2010). gld-2 mu-
tants are sterile, and, therefore, the role of this gene in poly(A)
tail synthesis has been examined in the germline alone. The
role of GLD-2, if any, in controlling mRNA translation in
C. elegans embryos has not been studied.
Genetic studies have identified several mRNA binding factors
that control cell fate specification during early C. elegans
embryogenesis. These factors include the KH domain protein
MEX-3 (Draper et al., 1996) and several tandem CCCH zinc-
finger proteins related to the vertebrate Tis11 gene, including
POS-1 andMEX-5 (Mello et al., 1992; Schubert et al., 2000; Tab-
ara et al., 1999). Although a few target mRNAs for these factors.
Figure 1. The pos-1 Gutless Phenotype Is
Suppressed by neg-1 Loss of Function
(A–C) Schematic diagrams showing key features
in endo-mesoderm differentiation in wild-type
and mutant backgrounds (as indicated). At the
four-cell stage (A), SKN-1 localization and APX-1
signaling restrict endo-mesoderm potential to the
blastomeres EMS and ABa. At the 12-cell stage,
MS signaling induces pharyngeal development
in adjacent ABa descendants. Finally, body
morphogenesis leads to enclosure of internal or-
gans inside a network of hypodermal cells (shown
in green). The germlineage P3 continues to divide
asymmetrically, producing the germline pre-
cursors Z2 and Z3 (purple). Defects in these events
are indicated in the mutant contexts (B and C).
(D–F) Polarized light micrographs showing gut
differentiation as indicated by birefringent gut
granule accumulation (D and F, absent in E).
(G) GFP fluorescence micrographs showing two
differentiation markers: AJM-1::GFP, which is ex-
pressed at cell-cell junctions of epidermal cells
surrounding the embryo (McMahon et al., 2001),
and PHA-4::GFP, which is expressed in the nuclei
of pharyngeal and intestinal precursors (Horner
et al., 1998).
(H and I) Failure of the AJM::GFP network to
enclose the anterior region of the embryo is indi-
cated by a dashed line, and PHA-4::GFP nuclear
staining, absent in (H), is restored in pos-1, neg-1
double mutants (I, arrows).have been identified, the targets, mechanism of regulation by
RNA binding, and developmental outcomes remain largely un-
known. For example, the tandem CCCH protein POS-1 is best
studied for its role in restricting the translation of the GLP-1
mRNA to the anterior of the early embryo (Ogura et al., 2003).
However, misregulation of GLP-1 (a Notch receptor homolog)
cannot explain the nearly complete lack of endo-mesoderm
specification observed in pos-1 mutant embryos.
Here we explore the role of POS-1 in early embryonic events
that specify endo-mesoderm precursor cells that give rise to
the majority of the C. elegans alimentary canal, including the
pharynx and intestine. The endo-mesoderm components of
the C. elegans alimentary canal are specified through both
cell-intrinsic and inductive mechanisms (Goldstein, 1992; Mello
et al., 1994; Priess and Thomson, 1987). A major endo-meso-
derm precursor cell named EMS produces the entire intestine
and the posterior portion of the pharynx. EMS is born through
two asymmetric divisions that sequentially segregate the po-
tential to express endo-mesoderm fates to the posterior sister
cell during the first division of the egg and then to the anterior
sister cell during the second division (Figure 1A). The transcrip-
tion factor SKN-1 is a major determinant of EMS development
and accumulates asymmetrically in early four-cell stage em-
bryos, where its levels become high in the posterior sister cells
EMS and P2 (Bowerman et al., 1992). SKN-1 activity is further
restricted to EMS through the activity of PIE-1, which localizes
in the nucleus of P2, where it prevents SKN-1 from activating
gene expression (Mello et al., 1992, 1996). In EMS, SKN-1 ac-
tivates the expression of endo-mesoderm-promoting transcrip-
tion factors, including MED-1, which promotes the expressionDevof downstream genes required for EMS development (Maduro
et al., 2001, 2007). Although POS-1 is critical for EMS specifi-
cation, the expression and localization of SKN-1 protein is
wild-type in pos-1 mutant embryos, suggesting that POS-1
promotes EMS differentiation through other still unknown
factors.
Here we identify GLD-2, GLD-3, and NEG-1 as factors whose
loss of function restores endoderm differentiation in pos-1
mutant embryos.We show that NEG-1::GFP accumulates asym-
metrically to higher levels in the nuclei of anterior blastomeres of
four-cell stage wild-type C. elegans embryos. GLD-2 and GLD-3
are required for NEG-1::GFP expression, whereas POS-1 is
required to restrict the accumulation of NEG-1 protein to anterior
blastomeres. We show that POS-1 binds directly to two
consensus binding sites in the neg-1 30 UTR and that POS-1 ac-
tivity correlates with short neg-1 mRNA poly(A) tails, whereas
GLD-2 and GLD-3 activities correlate with long neg-1 poly(A)
tails. Moreover, we employ a deep sequencing approach,
termed poly(A) Tail cDNA sequencing (PAT-seq), to analyze
poly(A) tail length transcriptome-wide in early embryos.We iden-
tify numerous transcripts whose poly(A) tail lengths depend
reciprocally on POS-1 activity and the activities of GLD-2
and GLD-3. Finally, we show that NEG-1 activity is required to
prevent anterior blastomeres from ectopically expressing
endo-mesoderm fates and that POS-1 restricts NEG-1 activity
to ensure proper endo-mesoderm development in the posterior.
Interestingly, the GLD-3 homolog Bicaudal-C antagonizes pos-
terior development in the anterior of Drosophila embryos, sug-
gesting that portions of this regulatory circuit are conserved
across phyla.elopmental Cell 34, 108–118, July 6, 2015 ª2015 Elsevier Inc. 109
Figure 2. NEG-1::GFP Is Expressed Asymmetrically in the Early
Embryo
Shown are representative confocal images of NEG-1::GFP rescuing neg-
1(tm6077) in otherwise WT, pos-1(zu148), and gld-3(RNAi) two-cell and four-
cell embryos.RESULTS
Restoration of the Gut in pos-1 Embryos
Gut specification requires the activity of SKN-1 and a down-
stream gene regulatory network, including the GATA transcrip-
tion factors MED-1 and END-1 (Bowerman et al., 1992; Maduro
et al., 2007). SKN-1 protein levels and distribution are unaffected
in the early blastomeres of pos-1 embryos (Tabara et al., 1999).
Downstream transcription factors such as MED-1 and END-1,
however, are not detected in the presumptive EMS lineage of
pos-1 embryos (data not shown). Moreover, analysis of the
med-1 mRNA by in situ hybridization revealed reduced levels
of med-1 mRNA relative to wild-type embryos (Figure S1A).
Together, these findings suggest that, although SKN-1 is ex-
pressed and localized properly in pos-1mutants, it fails to initiate
the gut developmental program. Consistent with this idea,
we found that overexpression of the downstream transcription
factor MED-1 using a multicopy transgenic array could bypass
the pos-1 gutless phenotype, restoring gut differentiation in
83% (618 of 762) of med-1(+++); pos-1 embryos (compared
with 2% [9 of 437] in pos-1(zu148) embryos).
Analysis of genetic interactions between pos-1 and a panel of
maternal RNA-binding proteins revealed that RNAi of the KH
domain gene gld-3 strongly suppresses the pos-1 gutless
phenotype (70.3% ± 11.6%, n = 144 embryos, and data not
shown; Figures S1B and S1C). This suppression resulted in em-
bryos with well differentiated endoderm and pharyngeal tissue
but did not correct other defects, including the failure in pos-1
mutants to properly specify the ABp fate through a GLP-1 medi-
ated interaction and the failure to properly specify the germline
cells Z2 and Z3. To search for additional factors whose loss of110 Developmental Cell 34, 108–118, July 6, 2015 ª2015 Elsevier Incfunction could restore gut development in pos-1 mutants, we
used RNAi to systematically screen a set of 944 genes annotated
previously as required for embryogenesis. Homozygous pos-1
hermaphrodites were exposed to RNAi, and their embryos
were then examined under a light microscope for intestinal bire-
fringence (Experimental Procedures).We found that RNAi target-
ing seven different genes restored gut differentiation in the pos-1
embryos (Table S1). In each case, as observed for gld-3(RNAi),
suppression of pos-1 was limited to the restoration of endo-
mesoderm differentiation, whereas proper ABp and P4 cell fates
were not restored (see below and data not shown).
Among the genes identified in our screen were gld-2, which
encodes a cytoplasmic poly(A) polymerase required for germline
development, and F32D1.6, which encodes a protein with no
obvious functional domains.We named this gene neg-1 because
of its negative effect on gut differentiation (note that, while this
study was under preparation, another study identified a role for
neg-1 in anterior morphogenesis [Osborne Nishimura et al.,
2015]). We found that knockdown of gld-2 by RNAi resulted in
sterility but that weak gld-2(RNAi) (Experimental Procedures) re-
sulted in partial suppression of pos-1 (41%, n = 38; Table S1).
RNAi of neg-1 caused a robust suppression of the pos-1 endo-
mesoderm differentiation defect (79%, n = 152; Table S1). Simi-
larly, the neg-1(tm6077) mutation restored endo-mesoderm
specification in pos-1 mutant embryos to 74% (n = 293), sug-
gesting that neg-1(tm6077) behaves like a loss-of-functionmuta-
tion (Figures 1F and 1I). The 407 bp neg-1(tm6077) deletion
removes approximately 60%of the of neg-1 open reading frame,
including the C-terminal 97 amino acids, and deletes a carboxy-
terminal domain in the NEG-1 protein that is conserved in homo-
logs found in related nematode species (Figure S5B).
POS-1 Restricts NEG-1::GFP Expression to Anterior Cell
Lineages
GLD-2 and GLD-3 have been proposed to activate translation of
target mRNAs by lengthening their poly(A) tails (Crittenden et al.,
2003; Eckmann et al., 2004; Wang et al., 2002). Therefore, an
attractive model is that GLD-2 and GLD-3 promote the expres-
sion of one or more endo-mesoderm antagonists and that
POS-1 functions in endo-mesoderm lineages to oppose GLD-2
and GLD-3 activities. NEG-1 could function with GLD-2 and
GLD-3 to promote the expression of such an antagonist. Alterna-
tively, NEG-1 itself might be the hypothetical endo-mesoderm
antagonist.
To begin to explore these possibilities, we engineered a strain
expressing a single-copy full genomic fusion neg-1::gfp trans-
gene (Frøkjaer-Jensen et al., 2008). Strikingly, we found that
NEG-1::GFP is asymmetrically localized in the early embryo (Fig-
ure 2; Movie S1). NEG-1::GFP was detected in the zygotic nu-
cleus and at equal levels in both nuclei of the two-cell embryo
(23 of 23). However, at the four-cell stage, NEG-1::GFP expres-
sionwasmarkedly higher in nuclei of the anterior AB blastomeres
than in the nuclei of EMS andP2 (31 of 34). Following the four-cell
stage, NEG-1::GFP remained high in the granddaughters of the
AB blastomere and diminished progressively in subsequent divi-
sions (data not shown). In the adult germline, we observed NEG-
1::GFP in the nuclei of distal germ cells and the nuclei of growing
oocytes except for the most proximal oocyte (Figure S2A).
Moreover, we observed intense sub-nuclear localization of.
NEG-1:GFP on condensed chromatin (11 of 11 NEG-1::GFP+
nuclei) (Figure S2B).
Next we examined the effect of POS-1, GLD-2, and GLD-3 ac-
tivities onNEG-1::GFP expression.We found that the asymmetry
in NEG-1::GFP expression was abolished in pos-1 mutant em-
bryos (Figure 2). Instead, NEG-1::GFP was expressed at high
levels characteristic of AB descendants in all lineages of the
pos-1(RNAi) (14 of 14) and pos-1(zu148) (6 of 6) embryos exam-
ined. In contrast, we found that NEG-1::GFP expression was
absent or greatly reduced at all embryonic stages in gld-2- and
gld-3-depleted embryos (Figure 2; data not shown). As ex-
pected, we found that gld-3 is epistatic to pos-1. NEG-1::GFP
expression, including its ectopic expression in EMS and P2,
was abolished in pos-1; gld-3 double mutants (n = 6). Taken
together, these findings suggest that POS-1 represses the
expression of NEG-1 in posterior blastomeres, whereas GLD-2
and GLD-3 are required to promote NEG-1 expression.
Consensus POS-1 Binding Elements Are Required for
NEG-1 Asymmetry
EarlyC. elegans embryos are transcriptionally quiescent (Guven-
Ozkan et al., 2008; Seydoux and Dunn, 1997), and, therefore,
regulation of NEG-1::GFP likely occurs at the level of mRNA
translation or protein stability. To ask whether NEG-1 expression
is regulated through the 30 UTR of the neg-1mRNA, we fused gfp
containing a nuclear localization sequence to the 30 UTR of neg-1
(hereafter called gfp::30UTRneg-1) and placed this reporter
under the promoter of the maternally expressed gene oma-1
(Experimental Procedures). We found that the pattern of GFP
expression from this reporter, which entirely lacks neg-1 coding
sequences, was identical to that of the full-length neg-1::gfp
fusion gene (Figure S3A; Movie S2). We therefore conclude
that the 30 UTR of neg-1 is sufficient to confer asymmetric
expression in the early embryo.
The 30 UTR of neg-1 contains three overlapping, predicted
RNA binding protein (RBP) elements, referred to here as the
RBP cluster (Figure 3A). This RBP cluster begins with a uracil-
rich sequence that represents a consensus MEX-5 binding re-
gion that is adjacent to overlapping MEX-3 and POS-1 predicted
binding elements (Farley et al., 2008; Pagano et al., 2007, 2009).
To address whether MEX-3, MEX-5, and POS-1 physically bind
to the RBP cluster, we carried out electrophoretic mobility
shift assays (EMSAs) and fluorescence polarization (FP) assays
(Experimental Procedures). We found that POS-1, MEX-3,
and MEX-5 bind the RBP cluster with affinities comparable
with those determined previously between each protein and
confirmed biological targets (Figures 3B and 3C) and that
MEX-5 binding to the RBP is favored over POS-1 binding (Fig-
ure S3B). Moreover, POS-1 binding was reduced when its puta-
tive binding site wasmutated (Figures 3B and 3C; Figure S3B). In
addition to binding within the RBP cluster, we found that MEX-5
binds a second region (M5B; Figures 3A and 3C). We also tested
an additional region 30 of the RBP cluster (P1M3B) that contains a
consensus POS-1 binding element and an overlapping MEX-3
consensus sequence (Figure 3A) and found that both recombi-
nant proteins bind this site with high affinity in vitro (Figures
S3C and S3D).
To determine whether these consensus binding elements
direct the in vivo regulation of NEG-1 expression, we generatedDevgfp::30UTRneg-1 reporters containing the same mutations as
those used for the in vitro binding assays. We found that muta-
tion of the predicted POS-1 binding element within the RBP
cluster caused a more symmetric distribution of NEG-1::GFP
between anterior and posterior blastomeres (Figure 3D, column
PBE1). Combining this lesion with a lesion in the second POS-1
binding element, P1M3B, completely abolished the anterior-
posterior asymmetry in NEG-1::GFP levels (Figure 3D, column
PBE1&2). Interestingly, this double binding site mutant consis-
tently exhibited NEG-1::GFP expression that, although equal be-
tween anterior and posterior blastomeres, was also lower in
intensity than levels observed in wild-type anterior nuclei (data
not shown), suggesting that one or both of these 30 UTR ele-
ments may also contribute positively to NEG-1 expression.
mex-5 Positively Regulates neg-1 Expression
MEX-5 and MEX-3 are enriched in anterior blastomeres (Draper
et al., 1996; Schubert et al., 2000), where NEG-1 protein levels
are high. Moreover, as shown above, these factors bind in vitro
to regions in the NEG-1 30 UTR that are also bound by POS-1
protein, raising the possibility thatMEX-5 andMEX-3 are positive
regulators of NEG-1 expression that directly compete with
POS-1 for binding. Consistent with this possibility, we found
that RNAi of mex-5 and mex-3 reduced the levels of NEG::GFP
expression. In the case of mex-3(RNAi), the asymmetry of
NEG-1::GFP expression was not affected, but the overall levels
appeared to be reduced slightly (Figure 3E; data not shown).
Strikingly, however, RNAi knockdown ofmex-5 completely abol-
ished NEG-1::GFP expression (0 of 30; Figure 3E). RNAi ofmex-
6, a partially redundant paralog of mex-5, did not affect NEG-
1::GFP expression (data not shown). The complete absence of
NEG-1 expression in mex-5(RNAi) early embryos is opposite to
the consequence of pos-1 loss of function. We therefore exam-
ined the consequences of mex-5 knockdown in a pos-1(zu148);
neg-1::gfp strain. We found that all pos-1(zu148); mex-5(RNAi)
early embryos exhibited bright NEG-1::GFP expression charac-
teristic of pos-1mutants (n = 14), including equal and high levels
of NEG-1::GFP in all blastomeres at the four-cell stage (n = 4;
Figure 3E). Similar results were obtained from pos-1(RNAi);
mex-5(RNAi) double knockdown embryos (Figure 3E). These
findings indicate that pos-1 is epistatic to and genetically down-
stream of mex-5 for the regulation of neg-1 expression and
suggest that MEX-5 protein promotes neg-1 expression in the
anterior by countering POS-1 repression. A previous study has
shown that the POS-1 protein exhibits wild-type localization in
mex-5 mutant embryos (Tenlen et al., 2006), suggesting that
the absence of neg-1 in mex-5(RNAi) embryos is not caused
by ectopic anterior accumulation of POS-1 protein. The finding
that in vitro binding sites for MEX-3, MEX-5, and POS-1 overlap
suggests that direct competition between these positive and
negative factors may contribute to NEG-1 regulation and may
also explain why mutating these elements abolishes both the
asymmetry and the overall level of NEG-1::GFP expression.
POS-1, GLD-2, and GLD-3 Regulate neg-1 Poly(A) Tail
Length
In the germline, GLD-2 and GLD-3 are thought to positively regu-
late gene expression by promoting the cytoplasmic polyadenyla-
tion of target mRNAs (Crittenden et al., 2003; Eckmann et al.,elopmental Cell 34, 108–118, July 6, 2015 ª2015 Elsevier Inc. 111
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Figure 3. POS-1 and MEX-5 Bind and Regu-
late the Expression of neg-1 mRNA
(A) Nucleotide sequence of a portion of the neg-1
mRNA 30 UTR indicating predicted binding sites for
POS-1 (gray), MEX-3 (orange), and MEX-5 (red).
WT and two sequences with mutations in the
POS-1 consensus elements (PBE1 and PBE1&2)
are shown.
(B) Fluorescence EMSAs with recombinant POS-1
and fluorescently labeled wild-type (RBPcWT) and
mutant (RBPc Mut) fragments of the neg-1 RBP
cluster (as indicated). The mobility of each labeled
probe is shown after incubation with increasing
amounts of POS-1 protein, as indicated at the
top of the gel images. The apparent dissociation
constant, KD,app, indicated below the gel images,
represents the average of three independent
replicates ± SD. A graphical quantification of the
data is shown at the right.
(C) Graphical representations of fluorescence po-
larization data obtained from incubating the fluo-
rescent probes (as indicated) with increasing
amounts of MEX-3 (left) or MEX-5 (right). The RBP
cluster probes were the same as those used in (B).
The sequence of the MEX-5 B probe (M5B) is
shown above the right graph. The KD,app values
were calculated as described in (B).
(D) Graphical representation of relative anterior/
posterior GFP intensity observed in four-cell stage
embryos transgenic for neg-1 promoter-driven
GFP under the control of the neg-1 WT or the
mutated neg-1 30 UTR. The mutations in the PBE1
and PBE1&2 UTRs are shown in (A). Relative
anterior/posterior GFP intensity after pos-1(RNAi)
is also indicated for comparison. The y axis in-
dicates the average ratio of GFP intensity in the
anterior (ABa + ABp) divided by intensity in the
posterior (EMS + P2) (Experimental Procedures).
Data are represented as mean ± SD. ***p < 0.0001.
Sample size (n) is indicated for each column.
(E) GFP fluorescence micrographs showing the
expression of a wild-type NEG-1::GFP reporter
in representative wild-type embryos (WT) and
embryos depleted by RNAi of various RBPs (as
indicated).2004; Wang et al., 2002). Indeed, several C. elegans transcripts
expressed in the germline have been shown to be dependent on
GLD-2 for their polyadenylation (Ja¨nicke et al., 2012; Kim et al.,
2010). Moreover, the neg-1 transcript is one of hundreds of tran-
scripts that have shortened poly(A)-tails in the sterile gld-2 adult
compared with wild-type adults (T.H.B., unpublished data). We
therefore asked whether GLD-2 and GLD-3 might exert their
positive effects on NEG-1 expression by promoting the polyade-
nylation of neg-1 mRNA in the embryo.112 Developmental Cell 34, 108–118, July 6, 2015 ª2015 Elsevier Inc.To measure the length of neg-1 poly(A)
tails in early embryos, we used a
deep sequencing approach termed PAT-
seq (Experimental Procedures; T.H.B.,
P.F.H., and D.R.P., unpublished data). If
NEG-1 regulation is achieved through
polyadenylation, then NEG-1 would be
expected to have long poly(A) tails inanterior blastomeres and short tails in posterior blastomeres. If
this difference in poly(A) tail length between blastomeres is
significantly large, we would detect two different populations
of tail lengths when analyzing whole embryos. Consistent with
this idea, we observed a bimodal distribution of neg-1 poly(A)
tail lengths in wild-type embryos (Figure 4A), with a clustering
of longer tails centered at around 80 A residues and a second
clustering of shorter tails centered at approximately 20 A resi-
dues in length (Figure 4B) (n = 318 tails). In pos-1 mutants, the
Figure 4. POS-1, GLD-3, and GLD-2 Regu-
late neg-1 mRNA Poly(A) Tail Length
(A) Graphical representation of neg-1 mRNA
poly(A) tail lengths as detected by PAT-seq anal-
ysis of RNA prepared from WT and mutant early
embryos (as indicated). Each dot represents a
cDNA sequence and the number A residues in its
poly(A) tail corresponding to its placement on the y
axis. A high density of dots may appear as a black
line. The red bar reflects the median according to
Kolmogorov-Smirnov test. *p % 0.05, **p % 0.01,
****p % 0.0001. The arrow denotes a range of
overrepresented poly(A) tail lengths in the WT that
increases in pos-1(RNAi) early embryos.
(B) A continuous histogram demonstrating the
percentage of poly(A) tails (y axis) longer than a
given length (x axis) in each genotype tested.density of reads with approximately 80 A residues was increased
andwasmore tightly clustered relative to the wild-type (WT) (Fig-
ures 4A, arrow, and 4B). Furthermore, the median poly(A) read
length was increased slightly (red bars in Figure 4A), as was
the average from 44.4 bases in the WT to 48.9 bases in pos-1
(n = 276 tails, p = 0.05). In contrast, read lengths were shifted
dramatically toward shorter tails in gld-3 and gld-2 depleted em-
bryos (Figures 4A and 4B), with an average length in gld-3(RNAi)
embryos of 25.3 (n = 250 tails, p = 0.00005) and in gld-2(RNAi)
embryos of 36.3 (n = 210 tails, p = 0.005). Taken together, these
findings suggest that POS-1 and GLD-2/GLD-3 regulate the
expression of NEG-1 by controlling the polyadenylation status
of neg-1 mRNA.
neg-1(+) Activity Represses Anterior Endo-mesoderm
Differentiation
To further analyze the function of neg-1, we characterized the
loss-of-function phenotypes associated with neg-1(RNAi) or
the deletion allele neg-1(tm6077). Interestingly, we found that
neg-1, like pos-1, is required maternally for proper embryonic
development. Approximately 75% of embryos produced by
the homozygous neg-1 mutant (or RNAi) mothers die before
hatching. In most cases, the dead embryos exhibit defective
morphogenesis, characterized by a failure of hypodermal cells
to properly enclose the anterior portion of the embryo (Figure 5A).
These findings suggest that neg-1(+) activity promotes anterior
cell fate specification and/or morphogenesis.
Because neg-1 is an antagonist of gut specification, we
wonderedwhether NEG-1might function duringwild-type devel-
opment to represses mesoderm or endoderm differentiation in
lineages that normally specify portions of the anterior hypoder-
mis. To explore this possibility, we examined the expression
pattern of PHA-4 in neg-1(tm6077). pha-4 encodes a FoxA
transcription factor expressed in mesodermal and endodermal
precursor cells (Du et al., 2014; Horner et al., 1998). Using 4Dmi-
croscopy to trace lineages (Hardin, 2011), we found that PHA-
4::GFP was expressed ectopically in anterior AB sub-lineages
of neg-1(tm6077) embryos, suggesting that NEG-1 prevents
PHA-4 expression in lineages that are normally destined to
become ectoderm (Figures 5B and 5C; Figure S4).
In addition to hypodermal lineages, neg-1 loss of function also
affects neuronal lineages. We therefore analyzed neg-1mutantsDevthat survived embryogenesis for behavioral deficits that might
reflect impaired neuronal function. We found that neg-1 worms
exhibit reduced osmotic avoidance. Wild-type L4 worms
avoided 2 M glycerol with an avoidance index of 0.63 ± 0.05
(n = 80), whereas neg-1 worms of the same stage scored
0.33 ± 0.06 (n = 60) (Figure 5E).
As described above, we found that overexpression of the
endo-mesoderm promoting transcription factor med-1 can
partially suppress the pos-1 gutless phenotype. We reasoned,
therefore, that med-1 loss of function might suppress ectopic
mesoderm differentiation and restore anterior development in
neg-1 embryos. Indeed, we found that med-1(ok804) dramati-
cally reduced embryonic lethality of neg-1(tm6077) from 75%
to 35.6% ± 13.3% (n = 1,545 embryos; Figure 5D). Notably,
the osmotic avoidance defect of neg-1 was also suppressed
(0.68 ± 0.06, n = 60; Figure 5E), suggesting that ectopic
mesoderm differentiation also causes the neg-1 behavioral
phenotype. Taken together, these findings suggest that NEG-1
functions in the anterior to ensure robust ectoderm specification,
at least in part, by preventing endo-mesoderm development and
that POS-1 promotes posterior endo-mesoderm differentiation
by restricting NEG-1 protein accumulation to the anterior.
DISCUSSION
Early embryonic patterning in C. elegans involves the precise
spatial and temporal control of mRNA translation (Begasse and
Hyman, 2011). Maternal mRNAs encoding transcription factors,
cell signaling components, and other developmental regula-
tors become differentially expressed in early embryonic cells,
contributing to the rapid diversification of cell fates (Hwang
and Rose, 2010). Here we explored the role of the RNA-binding
protein POS-1 in this process. We have shown that a maternal
mRNA encoding an endo-mesoderm repressor NEG-1 is a key
target for POS-1 regulation. Taken together, our genetic, molec-
ular, and localization studies support a model in which POS-1
binds to the neg-1mRNA and regulates its cytoplasmic poly-ad-
enylation (Figure 6A). Our findings suggest that POS-1 and its
homolog MEX-5 bind adjacent sequences in the neg-1 mRNA
30 UTR and have opposing effects on the recruitment of the cyto-
plasmic poly(A) polymerase GLD-2 and its co-factor GLD-3. In
anterior blastomeres, where MEX-5 levels are high (Schubertelopmental Cell 34, 108–118, July 6, 2015 ª2015 Elsevier Inc. 113
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Figure 5. neg-1 Prevents Ectopic Endo-
mesoderm Differentiation in the AB Lineage
(A) Nomarski light micrographs showing wild-
type and neg-1 embryos approximately midway
through body morphogenesis. The defective
anterior enclosure with resulting external pharyn-
geal tissue (white arrows) is indicated in the neg-1
embryo.
(B and C) Ectopic PHA-4::GFP expression in
neg-1() embryos.
(B) Fluorescence micrographs of a WT and neg-
1(tm6077) embryo expressing histone::mCherry
(marking all nuclei) and pha-4::gfp (marking
pharyngeal and endodermal cells). The white
arrowheads indicate ectopic pharyngeal cells in
the neg-1 embryo.
(C) Lineage diagrams constructed from 4D micro-
scopy studies on six independently analyzed
neg-1(tm6077) embryos. Wild-type lineages that
produce a pharynx are shown by red circles in the
diagram at the left. The neg-1 lineages that were
positive for PHA-4::GFP are shown at the right,
with the frequency of GFP detection indicated
inside each red circle. The diagram is a summary of
the lineages in Figure S4.
(D and E)med-1 loss of function suppresses neg-1
mutant phenotypes.
(D) Bar graph showing the percent embryonic
lethality in neg-1(tm6077) single mutant and
neg-1(tm6077); med-1(ok804)mutant embryos (as
indicated; n = number of embryos assayed). The
error bars indicate the mean ± SD.
(E) Bar graph showing the glycerol avoidance
index for the wild-type (n = 80) and the
neg-1(tm6077) (n = 60) and neg-1(tm6077); med-
1(ok804) (n = 60) double mutant strains (as indi-
cated). The larval stages analyzed, L1 through
adult, are indicated. The avoidance index
is calculated as the number of positive re-
sponses divided by the total number of trials (see
text) ± SEM.et al., 2000), MEX-5 overcomes POS-1 inhibition, leading to
GLD-2/GLD-3 recruitment, extension of neg-1 poly(A) tails,
and accumulation of NEG-1 protein, which, in turn, represses
endo-mesoderm fates, ensuring the proper expression of ecto-
dermal (skin and neuronal) cell fates. Conversely, in posterior
blastomeres, high POS-1 levels prevent GLD-2/GLD-3-medi-
ated activation of neg-1 mRNA translation and, therefore,
protect endo-mesoderm precursors from NEG-1 protein accu-
mulation (Figure 6B).
GLD-2 and GLD-3 as Regulators of Early Embryogenesis
Previouswork has demonstrated that GLD-2 andGLD-3 function
together during germline development to promote the transition
from mitosis to meiosis (Crittenden et al., 2003; Eckmann et al.,
2004; Wang et al., 2002). Here we have shown that GLD-2 and114 Developmental Cell 34, 108–118, July 6, 2015 ª2015 Elsevier Inc.GLD-3 also promote embryogenesis by
positively regulating the expression of
the endo-mesoderm inhibitor NEG-1.
Our findings suggest that GLD-2 and
GLD-3 promote NEG-1 expression bylengthening the poly(A) tail of neg-1 mRNA. Similar regulatory
interactions may control the expression of other proteins that
accumulate in anterior blastomeres. Of more than 5,000 genes
represented in our early embryo PAT-seq datasets, we identified
436 with ‘‘GLD-2/GLD-3-activated, POS-1-repressed’’ poly(A)
tail lengths (Figure 6C). These included mex-3, mex-5, mex-6,
and zif-1, whose protein products are enriched in the anterior in
a pattern similar to that of NEG-1 (DeRenzo et al., 2003; Draper
et al., 1996; Schubert et al., 2000). A recent study used oligo-
dT selection to recover mRNAs from isolated anterior and poste-
rior blastomeres of two-cell-stage C. elegans embryos (Osborne
Nishimura et al., 2015). Interestingly, comparing these data
to our PAT-seq data revealed that 40.5% (17 of 42) of the
AB-enriched mRNAs from the single-blastomere study, but
only 1.8% (2 of 112) of P1-enriched mRNAs, were among the
AB D
C
Figure 6. RBPs Control Cytoplasmic Polyadenylation of mRNAs to
Establish Anterior-Posterior Asymmetries
(A) Molecular regulation of neg-1 expression. MEX-5 and POS-1 bind the 30
UTR of neg-1. POS-1 prevents GLD-3/2 polyadenylation of neg-1 in posterior
lineages, and MEX-5 counters POS-1 repression in anterior lineages.
(B) Model for the regulation of cell fate specification in anterior and posterior
lineages (blue and red circles, respectively). The diagram indicates how the
regulation of mRNA translation by the RBPs POS-1 and MEX-5 ensures the
asymmetric accumulation of the endo-mesoderm activator (SKN-1) and of
the endo-mesoderm antagonist (NEG-1) and how the downstream activities of
these factors ensure the proper expression of ectodermal and endo-meso-
dermal transcriptional programs. MEX-5-negative regulation of SKN-1 and
POS-1 is based on Schubert et al. (2000).
(C) GLD-2/GLD-3-activated, POS-1-repressed genes are those that had
shorter tails upon gld-3 RNAi or gld-2 RNAi and longer poly(A) tails after pos-1
RNAi (overlap between both circles). This common group consists of 436
genes that include the anterior expressed neg-1, mex-3, mex-5, mex-6, and
zif-1. gld-3 and glp-1 qualify as GLD-2-activated, POS-1-repressed genes but
not as GLD-3-activated, POS-1-repressed genes.
(D) Model indicating how the regulatory circuit that controls neg-1 mRNA
expression may also explain the regulation of many other mRNAs, including
those of several genes studied previously (indicated).GLD-2/GLD-3-activated, POS-1-repressed group of mRNAs
identified byPAT-seq (Tables S2 andS3). These findings suggest
that the POS-1/GLD-2/GLD-3 interactions that regulate neg-1
poly(A) tail length may also function more generally to regulate
the asymmetric expression of dozens of targetmRNAs, including
neg-1, zif-1, andmex-3/5/6 (Figure 6C).DevIt is not yet known howGLD-2 and GLD-3 are recruited to their
targets. A structural study indicates that domains KH2-KH5 of
GLD-3 assemble a thumb-like structure that may present KH1
for direct contact with GLD-2 (Nakel et al., 2010; Eckmann
et al., 2004). These findings raise the question of whether
GLD-3 can bind bothmRNA andGLD-2 simultaneously and sug-
gest that, rather than directly binding RNA to recruit GLD-2,
GLD-3 may serve as an adaptor protein for GLD-2 recruitment
by other RNA-binding factors. One attractive possibility is that
CCCH-finger proteins contribute RNA-binding specificity that
determines which mRNAs are targeted for poly(A) tail length-
ening by GLD-2. With at least seven CCCH proteins (MEX-1,
POS-1, MEX-5, MEX-6, OMA-1, OMA-2, and PIE-1) implicated
in cell fate determination in early embryos, the combinatorial
complexity available for mRNA regulation is substantial. Hinting
at additional complexity, our findings reveal a subset of mRNAs
whose poly(A) tail lengths appear to depend on GLD-2 but not
GLD-3 activity (Figure 6D). Among these, the glp-1 mRNA has
been shown previously to be a target of POS-1-negative regula-
tion in the posterior of the embryo (Ogura et al., 2003). It will
therefore be interesting to determine whether a distinct GLD-2
complex that does not include GLD-3 activates GLP-1 mRNA
translation. It is also worth noting that the mRNA of the GLP-1
ligand APX-1, whose protein expression in the P2 blastomere
depends on POS-1(+) activity, is among a subset of mRNAs
whose poly(A) tail lengths were correlated positively with
GLD-2 and POS-1 (but not GLD-3 activity) (Table S3). Therefore,
in addition to its role as a negative regulator of neg-1 mRNA,
POS-1 may function as a positive regulator that recruits a
distinct GLD-2 complex to promote the lengthening of apx-1
mRNA poly(A) tails.
A Conserved Mechanism for Regulating
Anterior-Posterior Asymmetries?
How NEG-1 represses endo-mesoderm genes remains unclear.
NEG-1 does not contain recognizable sequence domains that
resemble other known functional elements, and only two homo-
logs have been identified in related nematodes (Figures S5A and
S5B). However, the nuclear localization of NEG-1 protein and its
association with chromatin suggest that NEG-1 may prevent
the activation of endo-mesoderm differentiation by acting as a
transcriptional repressor.
Despite the absence of sequence homologs in other organ-
isms, our findings suggest that NEG-1 partakes in a conserved
mechanism that controls embryonic asymmetry in metazoans.
Drosophila Bicaudal-C is required to prevent posterior (caudal/
abdominal) fates from appearing ectopically in the anterior of
the Drosophila embryo, a developmental function very similar
to that described here for C. elegans gld-3. Interestingly,
Drosophila Bicaudal-C appears to bind its own mRNA and
repress translation by recruiting components of a conserved
mRNA deadenylase complex (Chicoine et al., 2007). A recent
study suggests that the Xenopus homolog Bic-C represses the
expression of specific mRNAs in the vegetal hemisphere of early
embryos by directly binding the translational control element
present in their 30 UTRs (Zhang et al., 2014). How these repres-
sive functions of Bic-C proteins can be reconciled with our find-
ings that GLD-3 functions to promote mRNA poly(A) tail length
and gene expression remains to be seen. However, a dynamicelopmental Cell 34, 108–118, July 6, 2015 ª2015 Elsevier Inc. 115
interplay between activities that shorten and lengthen poly(A)
tails in the cytoplasm is thought to be central to the regulation
of mRNA translation during fly oogenesis and Xenopus oocyte
maturation (Ivshina et al., 2014). It is possible, therefore, that
Bic-C proteins mediate repression by shortening poly(A) tails
to promote mRNA turnover or to promote the storage of certain
mRNAs for later activation. Conversely, by engaging GLD-2 pro-
tein, Bic-C proteins may have the ability to reverse this repres-
sion, selectively re-activating specific mRNAs. Currently we do
not know how neg-1mRNA becomes de-adenylated. Therefore,
it will be interesting to determine whether GLD-3 plays a role in
recruiting a deadenylase complex to the neg-1 mRNA, perhaps
during oogenesis, to set the stage for re-adenylation later during
embryogenesis.
In both fly and frog oocytes, conserved RNA binding factors
called cytoplasmic polyadenylation element-binding proteins
(CPEBs) play a key role in recruiting the cytoplasmic poly(A)
polymerase GLD-2 to specific targets (Barnard et al., 2004;
Benoit et al., 2008; Cui et al., 2008). Although CPEB proteins
are conserved in C. elegans and have been shown to function
with GLD-2 to regulate germline development, we have not
found a role for CPEBs in regulating neg-1 mRNA polyadenyla-
tion or other embryonic events. Perhaps POS-1 and its CCCH
zinc-finger homologs provide RNA-binding and regulatory ac-
tivities in C. elegans that are analogous to those provided
by CPEB proteins in other organisms. There is clearly a rich
complexity of mRNA regulation in metazoan embryos, espe-
cially in embryos where important early developmental events
occur prior to the onset of zygotic transcription. It will be inter-
esting in the future to determine the extent to which cyto-
plasmic polyadenylation and the rich combinatorial complexity
of RNA-binding factors contribute to the remarkable unfolding
of early embryonic patterning, organogenesis, and neurogene-
sis across phyla.EXPERIMENTAL PROCEDURES
Strains
JJ462: +/nT1 IV; pos-1(zu148) unc-42(e270)/nT1 V.
WM317: neg-1(tm6077). The deletion was obtained by the National Bio-
resource Project (Mitani Laboratory) and removed a region encoding the
last 97 amino acids as well as the terminating stop codon of the gene,
therefore fusing the coding region with the 30 UTR and adding 11 codons
to the predicted gene product before encountering an in-frame stop
codon.
RW10425: stIs10116 [his-72(promoter)::his-24::mCherry + unc-119(+)].
stIs37 [pie-1(promoter)::mCherry::H2B + unc-119(+)]. stIs10389 [pha-
4::GFP::TY1::3xFLAG].
WM310: gfp::neg-1; neg-1(tm6077). A region of cosmid F32D1 flanked by
AflII and NotI digestion sites was subcloned, and an open reading frame
(ORF) encoding GFP was introduced upstream of F32D1.6 (gfp::neg-1).
The engineered transgene preserved neg-1 in its predicted operon and
its downstream neighbor fipp-1 and was introduced using MosSCI trans-
genesis (Frøkjaer-Jensen et al., 2008). gfp::neg-1 was crossed into the
neg-1(tm6077) background.
WM311: oma-1 promoter::NLS::gfp::neg-1 30UTR (J608.6).
WM312: oma-1 promoter::NLS::gfp::neg-1 30 UTR with a mutated POS-1
binding site (see RBPc Mut in Table S2).
WM316: neg-1(tm6077); med-1(ok804).
WM326: pos-1(zu148) unc-42 (e230) /hT1 [med-1::gfp, rol-6(su1006)].
WM319: oma-1 promoter::NLS::gfp::neg-1 30 UTR with two mutated
POS-1 binding elements.116 Developmental Cell 34, 108–118, July 6, 2015 ª2015 Elsevier Incmed-1 In Situ Hybridization
In situ hybridization was performed as described by Tabara et al. (1999).
Probes were designed against gfp mRNA and used to identify med-1::gfp in
the strain med-1::gfp, rol-6(su1006) (Maduro et al., 2001) before and after
pos-1(RNAi).
pos-1 Suppressor Screen
The pos-1 suppressor screen was performed by placing five to ten L2–L4 pos-
1(zu148) unc-42(e270) worms on RNAi food and allowing them to reach adult-
hood and lay eggs. Embryos were then scored for gut granules. Positive hits
were then retested by scoring the embryos (E) of four to six individual worms
(n) fed the RNAi food to assess overall gut development and obtain average
pos-1 suppression and SD. The same protocol was followed for gld-3 and
gld-2 suppression. For the effect of med-1 upregulation, a med-1::gfp multi-
copy transgenic array was crossed with pos-1(zu148) unc-42(e270), and em-
bryos of homozygous hermaphrodites were scored for gut granules.
Binding Assays
Fluorescence anisotropy and EMSAs using purified recombinant POS-1
(80–180),MEX-3 (45–205)andMEX-5 (236–350)weredoneasdescribedbyFar-
ley et al. (2008) andPagano et al. (2007, 2009), respectively. All RNA oligonucle-
otides used in this study were chemically synthesized and fluorescently labeled
at the 30 end with fluorescein amidite (FAM) by Integrated DNA Technologies.
Competition assays were set up similar to the EMSAs. 550 nM of POS-1
(80–180) or 450 nM MEX-5 (236–350) was added to the RNA equilibration
buffer to obtain a 70% RNA-bound complex. Then the corresponding
competing protein was titrated to the reaction mixture at varying concentra-
tions. After 3 hr of equilibration, the reaction mixture was run on a 5% native
polyacrylamide gel in 13 Tris-borate (TB) for 3 hr at 120 V. Quantifications
were done by determining the pixel intensity of the RNA species bound by pro-
tein relative to the pixel intensity of total RNA species to give the fraction bound
of RNA. The pixel intensities of each band were determined and background-
corrected by using Image Gauge (Fujifilm).
NEG-1::GFP Quantification
Time-lapse imaging of NEG-1::GFP was conducted by capturing GFP fluores-
cence (exposure time, 40 ms) at three different planes (z stacks) every 1 min
from the two- to six-cell stages. Images spanning the four-cell stage were
analyzed bymeasuring GFP intensity in nuclei (mean gray value) using ImageJ.
The three time points preceding the division of ABa and ABp were selected to
represent NEG-1::GFP intensity in the four-cell stage. GFP intensity of ABa and
ABp were summed for ‘‘anterior GFP,’’ and those of EMS and P2 were
summed for ‘‘posterior GFP’’ (NEG-1::GFP asymmetry = anterior GFP – poste-
rior GFP).
Embryonic Cell Lineaging and pha-4::gfp Expression
The EMS lineage was performed using the pha-4::gfp lineaging strain
RW10425 for the wild-type. The strain was fed pos-1 RNAi food to lineage
EMS in pos-1() embryos. The strain was crossed with pos-1(zu148) unc-
42(e270) and fed gld-3 RNAi food to lineage EMS in pos-1(); gld-3() em-
bryos. Lineaging was performed according to Du et al. (2014). The images of
pha-4::gfp expression generated during lineaging were used for Figure 6C.
PAT-Seq
The PAT-seq approach was utilized to determine the gene expression, poly(A)
site, and polyadenylation state of the transcriptome of early C. elegans em-
bryos having been depleted for a series of RNA binding proteins. pos-1 was
knocked down using double-stranded RNA (dsRNA)-expressed E. coli fed
to 100,000 starved/synchronized L1 larvae. When half of the population
reached adulthood and half were still in the L4 stage, worms were bleached
and embryos harvested and stored in Trizol. This ensured an enrichment of
early embryos between the 1- and 24-cell stage. Because prolonged gld-3
and gld-2 RNAi causes sterility, starved/synchronized L1 larvae were fed
diluted OP50 (200 ml of concentrated OP50 diluted in 2 ml of M9 and starved
L1s) for 16 hr. After this initial step, the OP50 was mostly consumed by the
larvae, and concentrated gld-3 or gld-2 dsRNA expressing E. coli was added
to the plates. When half of the population reached adulthood and half were still
in the L4 stage, worms were bleached and embryos harvested and stored in.
Trizol. Total RNA was isolated using standard procedures. For wild-type sam-
ples, synchronized L1s were fed OP50 until the aforementioned stage before
being processed as stated above. More than 90% knockdown of pos-1 and
gld-3 was confirmed by qPCR, whereas the gld-2 knockdown was approxi-
mately 50% (data not shown).
Osmotic Avoidance Test
A drop of glycerol (2 M) was delivered near the tail of a worm as it moved
forward. The glycerol drop instantly surrounds the worm and reaches the ante-
rior sensory organs. Wild-type worms immediately sense the glycerol as a
repellent and move backward. Backward movement was scored.
ACCESSION NUMBERS
The GEO accession number for the PAT-seq data reported in this paper is
GSE57993.
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